Jun 07, 2023 / 02:30PM GMT
Akash Tewari - Jefferies LLC, Research Division - Equity Analyst
All right. Good morning, everyone. For those who don't know me, my name is Akash Tewari, a pharma and biotech analyst here at Jefferies. I hope you guys are all enjoying our health care conference and the weather outside. It looked like kind of -- it looked like Blade Runner, it was a little surreal. But anyway, I have the pleasure of hosting Exelixis and Mike Morrissey, President and CEO. Mike, maybe I'll hand it off to you for some brief introductions, and then we'll get into some Q&A.
Michael M. Morrissey - Exelixis, Inc. - CEO, President & Director
Good. Sounds good. Good morning, everybody. Again, Mike Morrissey, Exelixis. Before I begin, I'll be making forward-looking statements today, so please see our SEC filings for a description of the risks that we face in our business. Go ahead.
Questions and Answers:
Akash Tewari - Jefferies LLC, Research Division - Equity AnalystPerfect. All right. So you and I were both at ASCO, our -- and
Trustpilot
